Credit score: CC0 Public Area
Remedy with gabapentinoids—medication equivalent to gabapentin and pregabalin—shouldn’t be straight related to an elevated danger of self-harm, finds a UK examine printed by The BMJ.
Nonetheless, charges of self-harm have been increased earlier than and shortly after remedy, highlighting the necessity for shut monitoring of sufferers all through their remedy journey, say the researchers.
Gabapentinoids are prescribed for circumstances equivalent to epilepsy, nerve ache, and nervousness problems.
Earlier research have raised issues about potential unwanted side effects, together with an elevated danger of self-harm, however didn’t study the dangers instantly earlier than beginning or after stopping gabapentinoids, even supposing these medication could also be prescribed for circumstances related to self-harm. As such, the character of this relationship remains to be not totally understood.
To acquire a clearer image, researchers analyzed digital well being information of 10,002 people within the UK aged 18 and over (common age 39; 67% feminine) who have been prescribed gabapentinoids between 2000 and 2020 and had at the least one hospital document of self-harm.
They examined charges of self-harm in 4 distinct time intervals for every particular person—90 days earlier than beginning remedy, the remedy interval, the 14 days after stopping remedy, and every other interval, which acted because the reference class.
By evaluating every particular person with themselves throughout time, the researchers have been capable of account for all potential confounding elements, together with genetic dangers, childhood atmosphere and early-onset circumstances. Additionally they accounted for age, seasonality, and different prescribed opioid and psychotropic medicines.
Of the ten,002 people, 4,767 (48%) took gabapentin solely, 3,164 (32%) took pregabalin solely and a couple of,071 (21%) took each over a mean follow-up interval of 13 years.
In contrast with the reference interval, the speed of self-harm elevated by 69% (16.8 per 100 particular person years) within the 90 days main as much as the beginning of remedy, suggesting that people prescribed these medication might already be at an elevated danger.
This danger declined throughout the remedy interval, however markedly elevated to 29.6 per 100 particular person years within the two-week interval after remedy had ended, earlier than returning to reference ranges, suggesting that gabapentinoids are unlikely to be linked to self-harm danger.
The researchers acknowledge that these are observational findings and outcomes could also be restricted by the small pattern sizes inside some teams. What’s extra, they have been solely capable of seize prescriptions issued by a basic practitioner and circumstances of self-harm extreme sufficient to be admitted to hospital.
However, their use of a big population-based database offered ample statistical energy to judge the affiliation between gabapentinoid use and self-harm, and the outcomes have been comparable after additional analyses, suggesting they’re strong.
This examine gives worthwhile insights into the affiliation between gabapentinoid remedy and self-harm dangers, they write. And whereas additional research are wanted in several populations, they are saying these findings “underscore the necessity for close patient monitoring of self-harm throughout the gabapentinoid treatment journey.”
This investigation reveals the significance of testing associations in major and secondary care, and the authors’ novel strategy of contemplating intervals earlier than and after remedy is a vital contribution, observe the researchers in a linked editorial.
They level to some essential examine limitations, however acknowledge that, “clinically, their results suggest that routine and periodic follow-up of people prescribed gabapentinoids should be considered, particularly in the weeks after medication has been discontinued.”
They add, “Whether young adults and people with no psychiatric diagnoses need more supervision while taking gabapentinoids requires further research to clarify.”
Extra data:
Affiliation of gabapentinoid remedy and the danger of self-harm: self-controlled, inhabitants primarily based case collection, The BMJ (2025). DOI: 10.1136/bmj-2024-081627
Offered by
British Medical Journal
Quotation:
Gabapentinoids unlikely to be straight linked to self-harm danger, examine finds (2025, April 30)
retrieved 30 April 2025
from https://medicalxpress.com/information/2025-04-gabapentinoids-linked.html
This doc is topic to copyright. Aside from any truthful dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.
